EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Intratumoral Enterobacter hormaechei drives gemcitabine resistance in pancreatic cancer via cdd L ‐mediated drug inactivation

Jun-Feng Peng, Meixia Li iD, Ting Niu, Judong Li iD, Wei Niu, Minghui Zheng, Quanjiang Ji, Chuan Li, Chenghao Shao iD, Kan Ding iD

iMeta · 2026-04 · 5 (2)

DOI: 10.1002/imt2.70126 ↗

Kurz gefasst

Leserbrief in der Zeitschrift iMeta, online erschienen am 29.04.2026. Verfasst von Jun-Feng Peng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Carbohydrate-Based Drug Research Center, CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materi…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Carbohydrate-Based Drug Research Center, CAS Key Laboratory of Receptor Research, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai China.
  • Department of Pancreatic-Biliary Surgery Second Affiliated Hospital of Naval Medical University Shanghai China.
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai China.
  • School of Physical Science and Technology & State Key Laboratory of Advanced Medical Materials and Devices Shanghai Tech University Shanghai China.
  • Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica Chinese Academy of Sciences, SSIP Healthcare and Medicine Demonstration Zone Zhongshan China.

ORCID-Profile: Meixia Li, Judong Li, Chenghao Shao, Kan Ding

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Peng, J. F., Li, M., Niu, T., Li, J., Niu, W., Zheng, M., Ji, Q., Li, C., Shao, C., & Ding, K. (2026). Intratumoral Enterobacter hormaechei drives gemcitabine resistance in pancreatic cancer via cdd L ‐mediated drug inactivation. iMeta, 5(2). https://doi.org/10.1002/imt2.70126

Vancouver

Peng JF, Li M, Niu T, Li J, Niu W, Zheng M, et al. Intratumoral Enterobacter hormaechei drives gemcitabine resistance in pancreatic cancer via cdd L ‐mediated drug inactivation. iMeta. 2026;5(2). doi:10.1002/imt2.70126

BibTeX
@article{Peng2026,
  author = {Peng, Jun-Feng and Li, Meixia and Niu, Ting and Li, Judong and Niu, Wei and Zheng, Minghui and Ji, Quanjiang and Li, Chuan and Shao, Chenghao and Ding, Kan},
  title = {Intratumoral Enterobacter hormaechei drives gemcitabine resistance in pancreatic cancer via cdd L ‐mediated drug inactivation},
  journal = {iMeta},
  year = {2026},
  volume = {5},
  number = {2},
  doi = {10.1002/imt2.70126}
}
Kostenlos starten →